Feed/Investors/PostScriptum

PostScriptum

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Venture capitalpostscriptum.comSince 2026-09-23

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$140M

across 1 round

LATEST ROUND

Series C · $140M · 2026-09-23

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

A London AI company that trains frontier models on its proprietary Trillion Gene Atlas to design therapeutics, starting with in vivo cell therapies

Series C$140M2026-09-2362

Company	Round	Amount	Announced	Role
Basecamp Research A London AI company that trains frontier models on its proprietary Trillion Gene Atlas to design therapeutics, starting with in vivo cell therapies	Series C Verified against 4 of 62 sources	$140M	2026-09-23	[ PART ]